---
layout: post
title: Telix (ASX:TLX), GMS, and Monash awarded $23 million in funding from the Federal Government
external_url: https://www.asx.com.au/asxpdf/20220404/pdf/457nk8vn4rhvm5.pdf
featured: true
date: '2022-04-04 16:01'
year: "2022"
categories: "linked"
tags: 

---

Biopharmaceutical company, [Telix Pharmaceuticals (ASX:TLS)](https://www2.asx.com.au/markets/company/TLX):

> announced that it is part of a $71.2 million Australian Precision Medicine Enterprise (APME) Project, which has been awarded $23 million in Federal Government grant under the Manufacturing Collaboration Scheme of Modern Manufacturing Initiative (MMI).
> 
> ...
>  
> The AMPE Project brings together industry partners Global Medical Solutions' (GMS) Autralian subsidary, Global Medical Solutions Australia (GMSA) and Telix Pharmaceuticals with Monash University to address Good Manufacturing Practice (GMP) manufacturing gap in Australian radoopharmaceuticals manufacturing sector.

Manufacturing an acronym soup.
